Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

FDA proposes new cybersecurity, supply chain and inspection laws for medical device manufacturers

March 29, 2022 By Jim Hammerand

Ventilators were in high demand during the first peaks of the COVID-19 pandemic. (Image from Raumedic)

The FDA today offered a slate of proposed laws for Congress to consider along with the agency’s $8.4 billion budget request for fiscal year 2023.

The legislative wish list includes several proposals that would affect medical device developers, manufacturers and distributors, including cybersecurity requirements for medical devices, mandatory supply chain reporting, remote inspections for FDA-regulated facilities and the destruction of dangerous imports.

Medical device cybersecurity

One proposal would require medical device manufacturers to design cybersecurity into their devices, such as the ability to update and patch software promptly. Manufacturers would also need to provide cybersecurity assurance in premarket submissions, include a software bill of materials that tells patients and doctors which components may be subject to cyber threats, and publicly disclose vulnerabilities when they surface and warn how users can protect themselves.

“These authorities are critical, as FDA has already seen and responded to several ransomware and other malware incidents within the healthcare sector,” the agency said in its proposal. “Stronger cybersecurity protections are necessary to ensure we remain prepared to protect patients and our healthcare workers on the front lines. Enacting FDA’s proposal would reduce the likelihood of harm to patients, interrupted access to devices, and loss of market share or market withdrawal for devices for which a vulnerability is identified as a result of cybersecurity incidents.”

Remote FDA inspections

Another proposal would allow the FDA to require manufacturers to cooperate with remote interactive inspections, which are currently voluntary for non-drug establishments.

“Reliance on voluntary requests is not sufficient to achieve effective and efficient oversight, as firms can refuse to provide records or other information in advance of or in lieu of an inspection or to participate in remote regulatory assessments,” the FDA said.

The proposal would give the FDA explicit authority to conduct remote regulatory assessments, including teleconferences, screen-sharing and livestreaming video of operations.

Supply chain reporting

The FDA wants expanded authority to detect and address supply chain shortages well before they become problems, citing the COVID-19 pandemic’s persistent strain on testing supplies and personal protective equipment. Seeking additional power outside of pandemics and other public health emergencies — for example, when product recalls and natural disasters cause shortages that put patients at risk — the FDA called for new ways to “assure a more resilient domestic supply chain and help reduce dependence on foreign production.”

Most significantly, the agency proposes that medical device manufacturers should notify the FDA “any time there is the potential for a shortage and provide production volume information.”

Manufacturers would also be required to assess supply chain risk, implement risk management plans and identify backup suppliers and manufacturing locations.

Additionally, the FDA wants permission to allow “temporary importation of unapproved devices, with appropriate scientific and regulatory controls, when in the interest of the public health” and allow devices to be “distributed past their labeled shelf life, with appropriate, supportive scientific data, when needed to prevent or mitigate a shortage.”

In a separate proposal aimed at shortages of critical drugs due to “unnecessarily short expiration dates,” the FDA wants drugmakers to study the maximum shelf life of drugs that are life-supporting, life-sustaining or that prevent or treat debilitating diseases and conditions. The law would include a financial penalty for noncompliance.

Imported product destruction

The FDA also wants legal authority to order the destruction of FDA-regulated imports that present significant public health risks and have been refused entry into the country.

The idea is to prevent product owners and consignees from attempting to move products that post health risks, and to prevent them from re-importing products that have been sent back. The importer of record would pay for the product destruction up front so the FDA and Customs and Border Protection don’t have to file legal action to recover those costs.

An executive summary of the FDA’s legislative proposals can be downloaded as a PDF here.

You may also like:


  • An even larger medtech supply chain shock looms beyond the…

Related Articles Read More >

A portrait of Keri Mattox, Zimmer Biomet's chief communications and administration officer
Zimmer Biomet adds ESG and CEO visibility to executive’s duties
A portrait of Geoff Martha, CEO of Medtronic
‘Catastrophic explosion’ and resin shortage led Medtronic’s supply chain problems
A portrait of Dr. Kevin Chung, chief medical officer at SeaStar Medical
Device developer SeaStar Medical hires chief medical officer
MedAcuity
MedAcuity hires SVP of business development

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech